Stocks
Deciphera Pharmaceuticals (DCPH) EBITDA margin US GAAP (year values) |
|||||||||
| FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -734.6% | -627.7% | -309.0% | -127.4% | -127.9% | -111.7% | ||
| Changes by years, y/y, % | +107pp | +319pp | +182pp | 0pp | -35.4% | ||||
Deciphera Pharmaceuticals. EBITDA margin, %
Deciphera Pharmaceuticals. EBITDA margin, changes, pp
Deciphera Pharmaceuticals (DCPH) EBITDA margin US GAAP (quarter values) |
||||||||
| FY2023Q1 | FY2023Q2 | FY2023Q3 | FY2023Q4 | FY2024Q1 | LTM ? | |||
| EBITDA margin, % | ? | -159.2% | -136.3% | -122.9% | -88.3% | -105.0% | -111.7% | |
| Changes by years, y/y, % | +1pp | -9pp | -10pp | +29pp | +54pp | |||
| Changes by quarters, q/q, % | -42pp | +23pp | +13pp | +35pp | -17pp | |||
